Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

June 28, 2019June 28, 2019

Study Investigates Role of Body Weight in Predicting Treatment Response in JIA

News

A new study reports that overweight and obese people with juvenile idiopathic arthritis (JIA) are more likely to have inflamed lower limb joints. The study also suggests that higher body weight ... Read more

June 21, 2019June 21, 2019

JIA Study Links Depression, Anxiety to Pain and Disability, Not Inflammation

News

A new study suggests that, in adolescents with juvenile idiopathic arthritis (JIA), anxiety and depression are associated with measures of pain and disability, but not with markers of inflammation. The ... Read more

June 18, 2019June 18, 2019

Researchers Call for More Studies on Possible Link Between JA, Celiac Disease

News

Contrary to previous reports, a new study of a group of patients with juvenile idiopathic arthritis found none with celiac disease. The investigators called for further research to better understand ... Read more

June 11, 2019June 11, 2019

Researchers Propose Algorithm to Guide Treatment for JIA Affecting the Jaw Joints

News

Researchers have developed an algorithm that may help with treatment decisions for people with juvenile arthritis that affects the jaw joints. The study, “An Algorithm for Management of Dentofacial Deformity ... Read more

April 12, 2019April 12, 2019

Case Report Supports Use of Xeljanz in Children with Systemic JIA

News

Xeljanz (tofacitinib) might be an effective and safe treatment for children with systemic juvenile idiopathic arthritis (JIA), a new case report suggests. The study, “Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic ... Read more

March 19, 2019

Machine Learning Used to Identify Changes in Immune System in JIA Patients, Study Reports

News

Researchers have used machine learning to identify changes to the immune system associated with juvenile idiopathic arthritis (JIA). Understanding these changes may lead to better diagnosis and treatment options for ... Read more